A detailed history of E Fund Management (Hong Kong) Co., Ltd. transactions in Moderna, Inc. stock. As of the latest transaction made, E Fund Management (Hong Kong) Co., Ltd. holds 3 shares of MRNA stock, worth $204. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3
Holding current value
$204
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 12, 2024

BUY
$101.21 - $166.61 $303 - $499
3 New
3 $0

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $26.7B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track E Fund Management (Hong Kong) Co., Ltd. Portfolio

Follow E Fund Management (Hong Kong) Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of E Fund Management (Hong Kong) Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on E Fund Management (Hong Kong) Co., Ltd. with notifications on news.